Vistagen Therapeutics (VTGN) Accumulated Expenses (2011 - 2026)
Vistagen Therapeutics (VTGN) reported Accumulated Expenses of $6.64 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 21.1% from $8.42 million a year earlier and down 28.1% from the prior quarter.
Vistagen Therapeutics (VTGN) Accumulated Expenses (2011 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Vistagen Therapeutics posted Accumulated Expenses of $8.76 million, down 0.6% from FY2025.
- Accumulated Expenses has a five-year compound annual growth rate of 41.1% (FY2021 to FY2026).
- By fiscal year, Accumulated Expenses came in at $8.81 million in FY2025 (+294.2%), $2.24 million in FY2024 (+180.8%), $796,000 in FY2023 (-40.1%) and $1.33 million in FY2022 (-14.9%).
- The fiscal Q2 2027 figure ranks as the lowest quarterly Accumulated Expenses since fiscal Q1 2026.
- Year over year, Accumulated Expenses gained in five of the last seven quarters, with growth averaging 101.0%.
- The high point for year-over-year Accumulated Expenses in five years was fiscal Q3 2022 (growth of 418.0%); the low point was fiscal Q3 2024 (a decline of 88.1%).
- Per Business Quant data, the three fiscal quarters before Q2 2027 came in at $9.24 million (Q1 2027), $8.76 million (Q4 2026) and $9.25 million (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | PetVivo Holdings | 3,096.39 Bn | 3,096.39 Bn | 196,075.00 |
| 2 | Eli Lilly | 1,202.70 Bn | 1,176.32 Bn | 20.46 Bn |
| 3 | Johnson & Johnson | 649.77 Bn | 569.63 Bn | 17.30 Bn |
| 4 | AbbVie | 507.00 Bn | 475.00 Bn | 13.12 Bn |
| 5 | Merck | 329.70 Bn | 292.64 Bn | 13.19 Bn |
| 6 | Novartis Ag | 291.91 Bn | 265.14 Bn | - |
| 7 | Amgen | 236.26 Bn | 187.91 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 207.15 Bn | 182.26 Bn | 6.73 Bn |
| 9 | Gsk | 193.54 Bn | 176.38 Bn | - |
| 10 | Vistagen Therapeutics | 7.34 Mn | -151.60 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 6.64 Mn |
| Jun 30, 2026 | 9.24 Mn |
| Mar 31, 2026 | 8.76 Mn |
| Dec 31, 2025 | 9.25 Mn |
| Sep 30, 2025 | 8.42 Mn |
| Jun 30, 2025 | 6.58 Mn |
| Mar 31, 2025 | 8.81 Mn |
| Dec 31, 2024 | 5.47 Mn |
| Sep 30, 2024 | 3.82 Mn |
| Jun 30, 2024 | 2.16 Mn |
| Mar 31, 2024 | 2.24 Mn |
| Dec 31, 2023 | 129,300.00 |
| Sep 30, 2023 | 292,600.00 |
| Jun 30, 2023 | 424,700.00 |
| Mar 31, 2023 | 796,000.00 |
| Dec 31, 2022 | 1.09 Mn |
| Sep 30, 2022 | 1.19 Mn |
| Jun 30, 2022 | 727,300.00 |
| Mar 31, 2022 | 1.33 Mn |
| Dec 31, 2021 | 2.63 Mn |
Vistagen Therapeutics Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=VTGN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "VTGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=VTGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();